Author

P. Caudana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

E. Piaggio· 2 shared S. Baulande· 2 shared W. Richer· 2 shared A. Debesset· 1 shared A. Nicolas· 1 shared A. Thiolat· 1 shared A. Vincent-Salomon· 1 shared B. Buttard· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Piaggio

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TNFR2 blockade promotes anti-tumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion

A. Debesset, C. Pilon, S. Meunier, O. Bonizec, W. Richer, A. Thiolat, C. Houppe, M. Ponzo, J. Magnan, P. Caudana, J. Tosello boari, S. Baulande, N. H. To, B. L. Salomon, E. Piaggio, , J. L. Cohen

This study shows that blocking TNFR2 reduces Treg activity and T cell exhaustion in PDAC, with improved efficacy when combined with CD40 agonists.

bioRxiv · Jan 22, 2024 · PreprintImmunology

Tissue-resident FOLR2+ macrophages associate with tumor-infiltrating CD8+ T cells and with increased survival of breast cancer patients.

R. N. Ramos, Y. Missolo-Koussou, Y. Gerber-Ferder, C. Bromley, M. Bugatti, N. G. Nunez, J. Boari Tosello, W. Richer, J. Denizeau, C. Sedlik, P. Caudana, F. Kotsias, L. L. Niborski, S. Viel, M. Bohec, , J. Helft

The paper identifies FOLR2+ macrophages in breast cancer that correlate with improved patient survival and co-localize with CD8+ T cells across multiple cancers.

bioRxiv · Apr 12, 2021 · PreprintImmunology